Krish Chandrasekaran

Dr. Krish Chandrasekaran

orcid

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1994 in Molecular Brain Research
Verified
Journal Article
Closed access
KCKrish Chandrasekaran
Krish Chandrasekaran
TGTony Giordano
Tony Giordano
DBDaniel R. Brady
Daniel R. Brady
JSJames Stoll
James Stoll
LMLee J. Martin
Lee J. Martin
SRStanley I. Rapoport
Stanley I. Rapoport

25 October 2006 in Mutagenesis
Verified
Journal Article
Open access
PDF file
GJGrace J.Kim
Grace J.Kim
KCKrish Chandrasekaran
Krish Chandrasekaran
WFWilliam F.Morgan
William F.Morgan
Radiation-induced genomic instability (RIGI) challenges the long-standing notion that radiation's effects derive solely from nuclear impact. In RIGI it is the unirradiated progeny that can display phenotypic changes at delayed times after irradiation of the parental cell. RIGI might well provide the driving force behind the development of radiation-induced tumorigenesis as most cancer cells even in pre-neoplastic states display multiple genetic alterations. Thus, understanding RIGI may help elucidate the mechanisms underlying radiation-induced carcinogenesis. One characteristic of clones of genetically unstable cells is that many exhibit persistently increased levels of reactive oxygen species (ROS). Furthermore, oxidants enhance and antioxidants diminish radiation-induced instability. However, much about the mechanisms behind the initiation and perpetuation of RIGI remains unknown and we examine the evidence for the hypothesis that oxidative stress and mitochondrial dysfunction may be involved in perpetuating the unstable phenotype in some cell clones surviving ionizing radiation.

1 May 2013 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
VNVamshi K. Nimmagadda
Vamshi K. Nimmagadda
CBChristopher T. Bever
Christopher T. Bever
NVNarasimha R. Vattikunta
Narasimha R. Vattikunta
STSaifi Talat
Saifi Talat
VAVakas Ahmad
Vakas Ahmad
TMTapas K. Makar
Tapas K. Makar
Treatment of experimental autoimmune encephalomyelitis (EAE) with resveratrol, an activator of sirtuin 1 (SIRT1), reduces disease severity. This suggested that activators of SIRT1, a highly conserved NAD-dependent protein deacetylase, might have immune-modulating or neuroprotective therapeutic effects in EAE. Previously, we showed that SIRT1 expression increases in EAE, suggesting that it is an adaptive response. In this study, we investigated the potential function of SIRT1 in regulating EAE using SIRT1-overexpressing mice. The current studies examine potential neuroprotective and immunomodulatory effects of SIRT1 overexpression in chronic EAE induced by immunization of C57BL/6 mice with myelin oligodendrocyte glycoprotein peptide 35–55. SIRT1 suppressed EAE clinical symptoms compared with wild-type EAE mice and prevented or altered the phenotype of inflammation in spinal cords; as a result, demyelination and axonal injury were reduced. Significant neuroprotective effects were observed, with fewer apoptotic cells found in the spinal cords of SIRT1-overexpressing EAE mice associated with increased brain-derived neurotrophic factor and NAD levels. Earlier, we showed that brain-derived neurotrophic factor and NAD play crucial neuroprotective roles in EAE. These results suggest that SIRT1 reduces neuronal loss in this chronic demyelinating disease model and that this is associated with a reduction in inflammation.

22 October 2008 in Glia
Verified
Journal Article
Closed access
PDF file
CDCamelia A. Danilov
Camelia A. Danilov
KCKrish Chandrasekaran
Krish Chandrasekaran
JRJennifer Racz
Jennifer Racz
LSLucian Soane
Lucian Soane
CZCarol Zielke
Carol Zielke
GFGary Fiskum
Gary Fiskum

21 July 2003 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
CMC. N. Madhavarao
C. N. Madhavarao
Christos ChinopoulosChristos Chinopoulos
Christos Chinopoulos
KCKrish Chandrasekaran
Krish Chandrasekaran
MNM. A. A. Namboodiri
M. A. A. Namboodiri

1 November 1996 in Experimental Neurology
Verified
Journal Article
Closed access
KCKrish Chandrasekaran
Krish Chandrasekaran
KHKimmo Hatanpää
Kimmo Hatanpää
DBDaniel R. Brady
Daniel R. Brady
SRStanley I. Rapoport
Stanley I. Rapoport